ANALYSIS OF SYMPTOMS PRESENTED BY PATIENTS WITH CORONAVIRUS DISEASE IN NOVA SANTA ROSA – PARANÁ

Authors

DOI:

https://doi.org/10.47820/recima21.v4i6.3418

Keywords:

COVID-19, Coronavirus, Symptom Assessment, Pandemics

Abstract

Objective: the study aims to analyze and quantify the symptoms presented by patients with coronavirus disease (COVID-19) in Nova Santa Rosa – Paraná, between June 2020 and June 2021. Methodology: data was collected at the Basic Unit Health Department manually directly from the notification forms and medical records and transferred to a digital spreadsheet. Results: 631 patients took part in the study, of which 581 (91%) were symptomatic and 50 (9%) asymptomatic. There were 26 different symptoms among the patients, the most common being cough (61%), headache (56%), sore throat (48%), myalgia (45%), fever (41%) and weakness (40%). Among the symptomatic ones, most were female and were between 31 and 40 years old. Both among men and among women the main symptom was coughing. In patients with some risk factor, cough was also the most observed symptom. The main risk factors among those infected were Hypertension (57%), Diabetes (20%) and heart disease (20%). Conclusion: from the analyzes it is concluded that in the study population, COVID-19 was more prevalent among women and young adults (31 to 40 years). It was found that cough was the most common symptom, as well as hypertension as the most observed risk factor. The analysis of symptoms is essential in a disease, in COVID-19 there was the presentation of several symptoms, some uncommon and rare, but the ones that most prevailed are very similar among the reports.

Downloads

Download data is not yet available.

Author Biographies

Agela Heloisa Bruxel

He has completed high school at Colégio Estadual Marechal Gaspar Dutra (2017) and graduated in pharmacy from Centro Universitário Assis Gurgacz.

Maycon Gabriel Duarte Teixeira

Medical student at Assis Gurgacz University Center.

Claudinei Mesquita da Silva

Graduated in Pharmacy with a specialization in Clinical Analysis from the State University of Maringá (1997-2001). Master's degree in Molecular Biology with a dissertation in the field of Biochemistry (2002-2004) from the Federal University of São Paulo (UNIFESP), and Doctorate in Health Sciences with a thesis in the area of Infectious and Parasitic Diseases from the State University of Maringá (2015-2018). Currently, he is a professor in the Chemistry and Clinical Analysis department at the University Center of the Assis Gurgacz Foundation. He has research projects related to clinical and toxicological analysis, where he holds the position of research leader

Leyde Daiane de Peder

She holds a doctorate from the Biosciences and Pathophysiology Program at the State University of Maringá (2018), a Master's degree in Sciences from the Federal University of São Paulo-Escola Paulista de Medicina (2006), and a bachelor's degree in Pharmacy and Biochemistry from the State University of Maringá (2003). She is currently a professor in the Pharmacy program at the University Center of the Assis Gurgacz Foundation and works as an appointed inspector in the Health Surveillance department of the Municipality of Cascavel.

References

Umakanthan S, Sahu P, Ranade A V., Bukelo MM, Rao JS, Abrahao-Machado LF, et al. Origin, transmission, diagnosis and management of coronavirus disease 2019 (COVID-19). Postgrad Med J. 2020;96(1142):753–8. Acesso em: 20 mar. 2021. Disponível em: https://pmj.bmj.com/content/96/1142/753.

Brasil, Secretarias Estaduais de Saúde, www.susanalitico.saude.gov.br. Covid-19 no Brasil. Acesso em: 27 mar. 2021. Disponível em https://susanalitico.saude.gov.br/extensions/covid-19_html/covid-19_html.html.

Brasil, Ministério da Saúde www.qsprod.saude.gov.br. Covid-19 no Brasil. Acesso em: 22 ago. 2021. Disponível em https://qsprod.saude.gov.br/extensions/covid-19_html/covid-19_html.html.

Hosseini E, Riahi N, Nikzad H. The novel coronavirus Disease-2019 (COVID-19): Mechanism of action, detection and recent therapeutic strategies. Virology. 2020;551(January):1–9. Disponível em: http://dx.doi.org/10.1016/j.virol.2020.08.011.

Gao Z, Xu Y, Sun C, Wang X, Guo Y, Qiu S, et al. A systematic review of asymptomatic infections with COVID-19. J Microbiol Immunol Infect [Internet]. 2021;54(1):12–6. Acesso em: 27 mar. 2021. Disponível em: https://doi.org/10.1016/j.jmii.2020.05.001.

Pereira, A. S., Shitsuka, D. M., Parreira, F. J., & Shitsuka, R. (2018). Metodologia da pesquisa científica. UFSM. https://www.ufsm.br/app/uploads/sites/358/2019/02/Metodologia-da-Pesquisa-Cientifica_final.pdf

Brasil, Instituto Brasileiro de Geografia e Estatística, www.ibge.gov.br. Nova Santa Rosa. Acesso em: 10 set. 2021. Disponível em https://www.ibge.gov.br/cidades-e-estados/pr/nova-santa-rosa.html.

Chams N, Chams S, Badran R, Shams A, Araji A, Raad M, et al. COVID-19: A Multidisciplinary Review. Front Public Heal. 2020;8(July):1–20.

Ochani RK, Asad A, Yasmin F, Shaikh S, Khalid H, Batra S, et al. Covid-19 pandemic: From origins to outcomes. A comprehensive review of viral pathogenesis, clinical manifestations, diagnostic evaluation, and management. Infez Med. 2021;29(1):20–36. Acesso em: 19 set. 2021. Disponível em: https://www.infezmed.it/index.php/article?Anno=2021&numero=1&ArticoloDaVisualizzare=Vol_29_1_2021_20.

Guo Y-R, Cao Q-D, Hong Z-S, Tan Y-Y, Chen S-D, Jin H-J, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status. Mil Med Res [Internet]. 2020 Dec 13;7(1):11. Acesso em: 26 set. 2021. Disponível em: https://mmrjournal.biomedcentral.com/articles/10.1186/s40779-020-00240-0

Oran DP, Topol EJ. The Proportion of SARS-CoV-2 Infections That Are Asymptomatic. Ann Intern Med [Internet]. 2021 May;174(5):655–62. Acesso em: 01 out. 2021. Disponível em: https://www.acpjournals.org/doi/10.7326/M20-6976

Aziz M, Goyal H, Haghbin H, Lee-Smith WM, Gajendran M, Perisetti A. The Association of “Loss of Smell” to COVID-19: A Systematic Review and Meta-Analysis. Am J Med Sci [Internet]. 2021;361(2):216–25. Acesso em: 01 out. 2021. Disponível em: https://doi.org/10.1016/j.amjms.2020.09.017.

Abate BB, Kassie AM, Kassaw MW, Aragie TG, Masresha SA. Sex difference in coronavirus disease (COVID-19): A systematic review and meta-analysis. BMJ Open. 2020;10(10):1–10. Acesso em: 03 out. 2021. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7539579/#R15.

Instituto Brasileiro de Geografia e Estatística. Pesquisa Nacional de Saúde, 2019. Percepção do estado de saúde, estilos de vida, doenças crônicas e saúde bucal. Acesso em: 18 out. 2021. Disponível em https://biblioteca.ibge.gov.br/index.php/biblioteca-catalogo?view=detalhes&id=2101764

de Souza TH, Nadal JA, Nogueira RJN, Pereira RM, Brandão MB. Clinical manifestations of children with COVID-19: A systematic review. Pediatr Pulmonol. 2020;55(8):1892–9. Acesso em: 19 set. 2021. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300659/pdf/PPUL-9999-na.pdf.

Safadi MAP. The intriguing features of COVID‐19 in children and its impact on the pandemic. J Pediatr (Versão em Port [Internet]. 2020;96(3):265–8. Acesso em: 01 out. 2021. Disponível em: https://doi.org/10.1016/j.jpedp.2020.04.001

Dhama K, Patel SK, Natesan S, Vora KS, Iqbal Yatoo M, Tiwari R, et al. COVID-19 in the elderly people and advances in vaccination approaches. Hum Vaccines Immunother [Internet]. 2020;16(12):2938–43. Aceso em: 21 set. 2021. Disponível em: https://doi.org/10.1080/21645515.2020.1842683.

Perrotta F, Corbi G, Mazzeo G, Boccia M, Aronne L, D’Agnano V, et al. COVID-19 and the elderly: insights into pathogenesis and clinical decision-making. Aging Clin Exp Res [Internet]. 2020;32(8):1599–608. Acesso em: 18 out. 2021. Disponível em: https://doi.org/10.1007/s40520-020-01631-y

Li Q, Zhao C. A review of the current status of clinical management of COVID-19 in the elderly. Med Sci Monit. 2021;27:1–10. Acesso em 20 out. 2021. Disponível em: https://pubmed.ncbi.nlm.nih.gov/33833211/

Setiati S, Harimurti K, Safitri ED, Ranakusuma RW, Saldi SRF, Azwar MK, et al. Risk factors and laboratory test results associated with severe illness and mortality in COVID-19 patients: A systematic review. Acta Med Indones [Internet]. 2020 Jul;52(3):227–45. Acesso em: 26 set. 2021. Disponível em: http://www.ncbi.nlm.nih.gov/pubmed/33020334.

Barbosa de Lima AL, Costa Lima K. [Id 54423] Fatores Prognósticos De Mortalidade Por Covid-19 No Rio Grande Do Norte, Brasil. Rev Bras Ciências da Saúde. 2021;25(2):225–34. Acesso em: 01 out. 2021. Disponível em: https://periodicos.ufpb.br/ojs2/index.php/rbcs/article/view/54423/34107.

Ejaz H, Alsrhani A, Zafar A, Javed H, Junaid K, Abdalla AE, et al. COVID-19 and comorbidities: Deleterious impact on infected patients. J Infect Public Health [Internet]. 2020;13(12):1833–9. Acesso em: 20 out. 2021. Disponível em: https://doi.org/10.1016/j.jiph.2020.07.014

Bansal M. Cardiovascular disease and COVID-19. Diabetes Metab Syndr Clin Res Rev [Internet]. 2020;14(3):247–50. Acesso em: 04 out. 2021. Disponível em: https://doi.org/10.1016/j.dsx.2020.03.013.

Akhmerov A, Marbán E. COVID-19 and the Heart. Circ Res [Internet]. 2020;1443–55. Available from: https://doi.org/10.1161/CIRCRESAHA.120.317055

Behzad S, Aghaghazvini L, Reza A, Gholamrezanezhad A. Extrapulmonary manifestations of COVID-19: Radiologic and clinical overview. Clin Imaging [Internet]. 2020;66(October):35–41. Acesso em: 19 set. 2021. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7233216/pdf/main.pdf.

Gasmi A, Peana M, Pivina L, Srinath S, Gasmi Benahmed A, Semenova Y, et al. Interrelations between COVID-19 and other disorders. Clin Immunol. 2021;224(December 2020). Acesso em 20 out. 2021. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833539/

Downloads

Published

28/06/2023

How to Cite

Bruxel, A. H., Teixeira, M. G. D., da Silva, C. M., & de Peder, L. D. (2023). ANALYSIS OF SYMPTOMS PRESENTED BY PATIENTS WITH CORONAVIRUS DISEASE IN NOVA SANTA ROSA – PARANÁ. RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218, 4(6), e463418. https://doi.org/10.47820/recima21.v4i6.3418

Issue

Vol. 4 No. 6 (2023): EDITORIAL - CLICK HERE TO ACCESS THE ARTICLES

Section

ARTIGOS

Categories

License

Copyright (c) 2023 RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Os direitos autorais dos artigos/resenhas/TCCs publicados pertecem à revista RECIMA21, e seguem o padrão Creative Commons (CC BY 4.0), permitindo a cópia ou reprodução, desde que cite a fonte e respeite os direitos dos autores  e contenham menção aos mesmos nos créditos. Toda e qualquer obra publicada na revista, seu conteúdo é de responsabilidade dos autores, cabendo a RECIMA21 apenas ser o veículo de divulgação, seguindo os padrões nacionais e internacionais de publicação.